12 Dec 2014 | 04:28 pm |
International law firm Pinsent Masons advised NanoTemper Technologies GmbH in its recent acquisition of SAW Instruments GmbH (Bonn, Germany).
By acquiring SAW Instruments and their proprietary Surface Acoustic Wave technology, NanoTemper expands its portfolio by an additional methodology for biomolecular interaction analysis.
The Pinsent Masons team was led by corporate partner, Tobias Rodehau, aligned by Dr. Florian Anselm, Legal Director, Olivia Irrgang and Marina Arntzen.
NanoTemper Technologies GmbH
NanoTemper Technologies, founded in 2008, is a globally operating high-tech company that develops, produces and markets instruments for biomolecular analytics. NanoTemper's proprietary technology MicroScale Thermophoresis (MST) allows identifying and developing drug candidates and enables customers to test the drugs' potency quickly and effectively.
Multinational law firm Pinsent Masons has announced a unique equality law specialism that supports clients in managing the cultural and legal aspects of discrimination and inclusion issues.
Multinational law firm Pinsent Masons has hired its second partner in Amsterdam recruiting corporate partner and civil-law notary Alexander Spoor as it boosts its technology, science and industry (TSI) capabilities in The Netherlands.
Multinational law firm Pinsent Masons has been recognised for its commitment to achieving gender equality, being named in The Times Top 50 Employers for Women report for the fifth consecutive year.
Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).
Multinational law firm Pinsent Masons has advised on the commercial close of four dialysis centres – a pathfinder public private partnership (PPP) implemented in Uzbekistan.
Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on